Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2008-01-22
2008-01-22
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001370, C424S001650, C424S009300, C424S009400, C424S009500, C534S014000
Reexamination Certificate
active
07320784
ABSTRACT:
The invention includes methods and compounds for labelling conjugates with metals which comprise the steps of coupling the conjugate to a support surface; introducing a complex-forming metal to the support; and collecting the metal-conjugate complex released from the support. The metal catalyzes cleavage of the conjugate from the support upon complex formation resulting in a solutions substantially free of unlabeled conjugate.
REFERENCES:
patent: 5659041 (1997-08-01), Dunn-Dufault et al.
patent: 5789555 (1998-08-01), Pollak
patent: 6027711 (2000-02-01), Sharma
patent: 6406297 (2002-06-01), Raymond et al.
patent: 6921526 (2005-07-01), Hoffman et al.
patent: WO 93 17719 (1993-09-01), None
patent: WO 96 037427 (1996-02-01), None
patent: WO 99 40947 (1999-08-01), None
Golub et al., Science, Oct. 15, 1999, pp. 531-537.
Smith, C.J. et al. “Evaluation of a Novel N3S Chelation System for the Preparation of Tc-99m and Re-188 Labeled Biomolecules,”J. Nuclear Med. (May 1998)) vol. 39, No. 5 Suppl.:215 : 45th Annual Meeting of the Society of Nuclear Medicine, Toronto, Ontario, Canada Jun. 7-11, 1998 Society of Nuclear Medicine.
Wong, Ernest et al. “Synthesis and Structural Characterization of Tc-99m and Re oxo Complexes with N1-N′2S1Peptidic Ligands.”J. Nuclear Med., (1997) vol. 38, No. 5 Supp.:148: 44th Annual Meeting of the Society of Nuclear Medicine, San Antonio, Texas, USA, Jun. 1-5, 1997.
Pollak, A., et al., “Inflammation with Novel Peptidic Technetium-99m Chelators Linked to a Chemotactic Peptide”, J. Nuclear Med., vol. 35 (5) Suppl. Jun. 1994, 44P-45P, Proceedings of the 41st Annual Meeting, New York City, NY.
Knight, L.C., :Thrombus Imaging with Technetium-99m Synthetic Peptides Based upon the Binding of a Monoclonal Antibody to Activated Platelets, J. Nuclear Med. vol. 95 (2) Feb. 1994, 282-288.
Lu Linda Fung
Pollak Alfred
Pollock Catherine M.
Roe David
Thornback John
Bracco Imaging S.p.A.
Jones Dameron L.
Kramer Levin Naftalis & Frankel LLP
LandOfFree
Immobilized labeling compounds and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immobilized labeling compounds and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immobilized labeling compounds and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2775504